314 filings
Page 6 of 16
8-K
y1m bis2zh30lgomsyi3
17 Dec 20
Regulation FD Disclosure
8:11am
8-K
cwff5rswd yf3s24v
1 Dec 20
Histogen Announces Preliminary Week 18 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
8:05am
D
2nrzy8dr q1ad3f
18 Nov 20
$189.21K in options / securities to be acquired, sold $189.21K, 7 investors
4:41pm
8-K
n8k 6o7kuvu
16 Nov 20
Histogen Announces Closing of $4.5 Million Registered Direct Offering
4:10pm
424B5
b0du2cqy7z941y4vs6vl
12 Nov 20
Prospectus supplement for primary offering
5:14pm
8-K
bb7ov7p6koa7bgq
12 Nov 20
Histogen Announces $4.5 Million Registered Direct Offering
8:20am
8-K
bqqrz7
10 Nov 20
Histogen Reports Third Quarter 2020 Earnings and Provides Business Update
4:15pm
8-K
i2np 8wzdsxb2q5ws
27 Oct 20
Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19
8:05am
8-K
4viuvtxg
29 Sep 20
Histogen Announces Update for its HST-002 Dermal Filler Program
8:15am
8-K
3j7iyz71 p1ip
27 Aug 20
Other Events
5:22pm
424B5
g9s7e8e e1
27 Aug 20
Prospectus supplement for primary offering
5:20pm
EFFECT
za0tog0
27 Aug 20
Notice of effectiveness
12:15am
CORRESP
usxskfv9xj1lz4fpb3bx
24 Aug 20
Correspondence with SEC
12:00am
UPLOAD
fd0td6w hgr
24 Aug 20
Letter from SEC
12:00am
8-K
fkancmsqhq05fb
13 Aug 20
Histogen Reports Second Quarter 2020 Earnings and Provides Business Update
4:10pm
8-K
hui198hypk3008db8 mx
10 Aug 20
Regulation FD Disclosure
12:00am